Contact Us
Muscle Pain Treatment Global Market Report 2025
Global Muscle Pain Treatment Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Muscle Pain Treatment Global Market Report 2025

By Pharmacological Treatment (Analgesics, Muscle Relaxants, Topical Analgesics, Other Pharmacological Treatments), By Non-Pharmacological Treatment (Physical Therapy, Massage Therapy, Acupuncture, Heat And Cold Therapy, Exercise And Stretching, Other Non-Pharmacological Treatments), By Type Of Pain (Acute Muscle Pain, Chronic Muscle Pain), By Cause Of Muscle Pain (Overuse And Strain, Injury Or Trauma, Inflammatory Conditions, Neurological Conditions, Infections, Other Cause Of Muscle Pain), By Application (Hospital, Clinic, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Muscle Pain Treatment Market Overview

• Muscle Pain Treatment market size has reached to $12.95 billion in 2024

• Expected to grow to $16.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%

• Growth Driver: Impact Of Rising Musculoskeletal Disorders On The Muscle Pain Treatment Market

• Market Trend: Innovative Solutions Driving Growth In The Muscle Pain Treatment Market

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Muscle Pain Treatment Market?

Muscle pain treatment refers to the management and alleviation of discomfort and inflammation affecting muscles. It typically involves rest, application of heat or cold therapy, over-the-counter pain relievers, and sometimes physical therapy or prescription medications for severe cases. The effective treatment aims to reduce pain, promote healing, and restore normal muscle function.

The main pharmacological treatments for muscle pain treatment are analgesics, muscle relaxants, topical analgesics, and others. Analgesics refer to medications designed to relieve pain without causing loss of consciousness. Non-pharmacological treatments include physical therapy, massage therapy, acupuncture, heat and cold therapy, exercise and stretching, and others. These treatments address different types of pain, including acute muscle pain and chronic muscle pain caused by overuse and strain, injury or trauma, inflammatory conditions, neurological conditions, infections, and others. They are applied in settings such as hospitals, clinics, and others.

Muscle Pain Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Muscle Pain Treatment Market Size 2025 And Growth Rate?

The muscle pain treatment market size has grown strongly in recent years. It will grow from $12.95 billion in 2024 to $13.59 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to aging population with a higher incidence of chronic pain conditions, an increase in sports injuries due to higher participation rates, the prevalence of manual labor jobs leading to musculoskeletal disorders, sedentary lifestyles contributing to muscle stiffness and pain, and a lack of exercise causing muscle atrophy and pain.

What Is The Muscle Pain Treatment Market Growth Forecast?

The muscle pain treatment market size is expected to see strong growth in the next few years. It will grow to $16.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing adoption of non-opioid and non-invasive pain management treatments, rising healthcare expenditures and demand for effective pain management solutions, regulatory approvals for new pain management therapies and devices, emphasis on preventive healthcare to mitigate chronic pain conditions, and growing demand for alternative therapies like acupuncture and chiropractic care. Major trends in the forecast period include telehealth and virtual consultations for pain management, the development of wearable pain relief devices and smart clothing, biopharmaceutical innovations in pain treatment, AI-driven personalized pain management solutions, and regenerative medicine techniques for tissue repair and pain reduction.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of electromyography (EMG) devices and compounded pain creams sourced from Canada and Italy, thereby limiting non-opioid treatment options and elevating physical medicine costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Muscle Pain Treatment Market Segmented?

1) By Pharmacological Treatment: Analgesics, Muscle Relaxants, Topical Analgesics, Other Pharmacological Treatments

2) By Non-Pharmacological Treatment: Physical Therapy, Massage Therapy, Acupuncture, Heat And Cold Therapy, Exercise And Stretching, Other Non-Pharmacological Treatments

3) By Type Of Pain: Acute Muscle Pain, Chronic Muscle Pain

4) By Cause Of Muscle Pain: Overuse And Strain, Injury Or Trauma, Inflammatory Conditions, Neurological Conditions, Infections, Other Cause Of Muscle Pain

5) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen

2) By Muscle Relaxants: Centrally Acting Muscle Relaxants, Peripherally Acting Muscle Relaxants

3) By Topical Analgesics: Creams & Ointments, Gels & Sprays, Patches

4) By Other Pharmacological Treatments: Corticosteroids, antidepressants, Anticonvulsants

What Is Driving The Muscle Pain Treatment Market? Impact Of Rising Musculoskeletal Disorders On The Muscle Pain Treatment Market

The increasing prevalence of musculoskeletal disorders is expected to drive the muscle pain treatment market going forward. Musculoskeletal disorders refer to conditions affecting the muscles, bones, and joints of the body, often causing pain, stiffness, and impaired movement. The rise in musculoskeletal cases is attributed to factors such as aging populations, sedentary lifestyles, and the increasing prevalence of chronic conditions. Muscle pain treatment aims to alleviate symptoms of musculoskeletal disorders by reducing pain, improving mobility, preventing complications, and enhancing patients' overall quality of life and functional abilities. For instance, in November 2023, according to a study conducted by The Lancet, a UK-based medical journal, an estimated 494 million people globally experienced other musculoskeletal disorders in 2020, with projections indicating a potential 115% increase by 2050. Therefore, the increasing prevalence of musculoskeletal disorders is driving the muscle pain treatment industry.

Who Are The Major Players In The Global Muscle Pain Treatment Market?

Major companies operating in the muscle pain treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy

What Are The Key Trends Of The Global Muscle Pain Treatment Market? Innovative Solutions Driving Growth In The Muscle Pain Treatment Market

Major companies operating in the muscle pain treatment market are focused on developing innovative solutions, such as topical analgesic products, to enhance efficacy and user convenience. Topical analgesic products are medications applied directly to the skin to relieve pain by targeting the affected area and are commonly used for conditions such as muscle aches, arthritis, and minor injuries. For instance, in July 2024, Wellness Formulations LLC, a US-based company providing health and wellness products, launched Ralli Rapid Pain Relief, a new product featuring menthol's pain-relieving benefits combined with advanced penetration enhancers and skin conditioners. It delivers effective pain relief without leaving a greasy residue, offering quick and lasting relief from muscle aches, joint pain, arthritis, strains, and sprains. Available in gel, spray, and roll-on formats, IT provides convenient application directly to the affected area, eliminating the need for rubbing or massaging.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Muscle Pain Treatment Market? Athletico's Acquisition Of Pivot Health Enhances Muscle Pain Treatment Services Nationwide

In February 2022, Athletico Physical Therapy, a US-based company providing physical therapy and orthopedic rehabilitation services, acquired Pivot Health Solutions for an undisclosed amount. This acquisition significantly bolsters Athletico's muscle pain treatment market presence through expanded geographic coverage, enhanced physical therapy and occupational health capabilities, seasoned leadership, and a commitment to delivering superior patient care standards. Pivot Health Solutions is a US-based provider of physical therapy, occupational health, and onsite corporate health services, including muscle pain and other physical ailments.

What Is The Regional Outlook For The Global Muscle Pain Treatment Market?

North America was the largest region in the muscle pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Muscle Pain Treatment Market?

The muscle pain treatment market consists of revenues earned by entities by providing services such as chiropractic care, hydrotherapy, occupational therapy, transcutaneous electrical nerve stimulation (TENS), cognitive-behavioral therapy (CBT), and myofascial release therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle pain treatment market also includes sales of acetaminophen, corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Muscle Pain Treatment Industry?

The muscle pain treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the muscle pain treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Muscle Pain Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $13.59 billion
Revenue Forecast In 2034 $16.66 billion
Growth Rate CAGR of 5.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Pharmacological Treatment: Analgesics, Muscle Relaxants, Topical Analgesics, Other Pharmacological Treatments
2) By Non-Pharmacological Treatment: Physical Therapy, Massage Therapy, Acupuncture, Heat And Cold Therapy, Exercise And Stretching, Other Non-Pharmacological Treatments
3) By Type Of Pain: Acute Muscle Pain, Chronic Muscle Pain
4) By Cause Of Muscle Pain: Overuse And Strain, Injury Or Trauma, Inflammatory Conditions, Neurological Conditions, Infections, Other Cause Of Muscle Pain
5) By Application: Hospital, Clinic, Other Applications Subsegments: 1) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen
2) By Muscle Relaxants: Centrally Acting Muscle Relaxants, Peripherally Acting Muscle Relaxants
3) By Topical Analgesics: Creams & Ointments, Gels & Sprays, Patches
4) By Other Pharmacological Treatments: Corticosteroids, Antidepressants, Anticonvulsants
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Muscle Pain Treatment Market Characteristics

3. Muscle Pain Treatment Market Trends And Strategies

4. Muscle Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Muscle Pain Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Muscle Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Muscle Pain Treatment Market Growth Rate Analysis

5.4. Global Muscle Pain Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Muscle Pain Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Muscle Pain Treatment Total Addressable Market (TAM)

6. Muscle Pain Treatment Market Segmentation

6.1. Global Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Analgesics

Muscle Relaxants

Topical Analgesics

Other Pharmacological Treatments

6.2. Global Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Physical Therapy

Massage Therapy

Acupuncture

Heat And Cold Therapy

Exercise And Stretching

Other Non-Pharmacological Treatments

6.3. Global Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Muscle Pain

Chronic Muscle Pain

6.4. Global Muscle Pain Treatment Market, Segmentation By Cause Of Muscle Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Overuse And Strain

Injury Or Trauma

Inflammatory Conditions

Neurological Conditions

Infections

Other Cause Of Muscle Pain

6.5. Global Muscle Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Clinic

Other Applications

6.6. Global Muscle Pain Treatment Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Acetaminophen

6.7. Global Muscle Pain Treatment Market, Sub-Segmentation Of Muscle Relaxants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Centrally Acting Muscle Relaxants

Peripherally Acting Muscle Relaxants

6.8. Global Muscle Pain Treatment Market, Sub-Segmentation Of Topical Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Creams & Ointments

Gels & Sprays

Patches

6.9. Global Muscle Pain Treatment Market, Sub-Segmentation Of Other Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Corticosteroids

Antidepressants

Anticonvulsants

7. Muscle Pain Treatment Market Regional And Country Analysis

7.1. Global Muscle Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Muscle Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Muscle Pain Treatment Market

8.1. Asia-Pacific Muscle Pain Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Muscle Pain Treatment Market

9.1. China Muscle Pain Treatment Market Overview

9.2. China Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Muscle Pain Treatment Market

10.1. India Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Muscle Pain Treatment Market

11.1. Japan Muscle Pain Treatment Market Overview

11.2. Japan Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Muscle Pain Treatment Market

12.1. Australia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Muscle Pain Treatment Market

13.1. Indonesia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Muscle Pain Treatment Market

14.1. South Korea Muscle Pain Treatment Market Overview

14.2. South Korea Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Muscle Pain Treatment Market

15.1. Western Europe Muscle Pain Treatment Market Overview

15.2. Western Europe Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Muscle Pain Treatment Market

16.1. UK Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Muscle Pain Treatment Market

17.1. Germany Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Muscle Pain Treatment Market

18.1. France Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Muscle Pain Treatment Market

19.1. Italy Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Muscle Pain Treatment Market

20.1. Spain Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Muscle Pain Treatment Market

21.1. Eastern Europe Muscle Pain Treatment Market Overview

21.2. Eastern Europe Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Muscle Pain Treatment Market

22.1. Russia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Muscle Pain Treatment Market

23.1. North America Muscle Pain Treatment Market Overview

23.2. North America Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Muscle Pain Treatment Market

24.1. USA Muscle Pain Treatment Market Overview

24.2. USA Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Muscle Pain Treatment Market

25.1. Canada Muscle Pain Treatment Market Overview

25.2. Canada Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Muscle Pain Treatment Market

26.1. South America Muscle Pain Treatment Market Overview

26.2. South America Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Muscle Pain Treatment Market

27.1. Brazil Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Muscle Pain Treatment Market

28.1. Middle East Muscle Pain Treatment Market Overview

28.2. Middle East Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Muscle Pain Treatment Market

29.1. Africa Muscle Pain Treatment Market Overview

29.2. Africa Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Muscle Pain Treatment Market Competitive Landscape And Company Profiles

30.1. Muscle Pain Treatment Market Competitive Landscape

30.2. Muscle Pain Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Muscle Pain Treatment Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Sanofi SA

31.3. Bristol Myers Squibb Company

31.4. AstraZeneca PLC

31.5. Novartis International AG

31.6. GlaxoSmithKline plc (GSK)

31.7. Eli Lilly and Company

31.8. Amgen Inc.

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Baxter International Inc.

31.11. Haleon Plc

31.12. Select Medical Holdings Corporation

31.13. Purdue Pharma

31.14. Endo Pharmaceuticals Inc.

31.15. Concentra Inc.

32. Global Muscle Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Muscle Pain Treatment Market

34. Recent Developments In The Muscle Pain Treatment Market

35. Muscle Pain Treatment Market High Potential Countries, Segments and Strategies

35.1 Muscle Pain Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Muscle Pain Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Muscle Pain Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Muscle Pain Treatment Market, Segmentation By Cause Of Muscle Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Muscle Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Muscle Pain Treatment Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Muscle Pain Treatment Market, Sub-Segmentation Of Muscle Relaxants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Muscle Pain Treatment Market, Sub-Segmentation Of Topical Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Muscle Pain Treatment Market, Sub-Segmentation Of Other Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Muscle Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Muscle Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Johnson & Johnson Financial Performance
  • Table 82: Roche Holding AG Financial Performance
  • Table 83: Merck & Co. Inc. Financial Performance
  • Table 84: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Muscle Pain Treatment Market, Segmentation By Cause Of Muscle Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Muscle Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Muscle Pain Treatment Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Muscle Pain Treatment Market, Sub-Segmentation Of Muscle Relaxants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Muscle Pain Treatment Market, Sub-Segmentation Of Topical Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Muscle Pain Treatment Market, Sub-Segmentation Of Other Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Muscle Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Muscle Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Johnson & Johnson Financial Performance
  • Figure 82: Roche Holding AG Financial Performance
  • Figure 83: Merck & Co. Inc. Financial Performance
  • Figure 84: AbbVie Inc. Financial Performance

Frequently Asked Questions

Muscle pain treatment refers to the management and alleviation of discomfort and inflammation affecting muscles. It typically involves rest, application of heat or cold therapy, over-the-counter pain relievers, and sometimes physical therapy or prescription medications for severe cases. The effective treatment aims to reduce pain, promote healing, and restore normal muscle function. For further insights on this market, request a sample here

The market major growth driver - Impact Of Rising Musculoskeletal Disorders On The Muscle Pain Treatment Market. For further insights on this market, request a sample here

The muscle pain treatment market size has grown steadily in recent years. It will grow from $12.95 billion in 2024 to $13.59 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to aging population with a higher incidence of chronic pain conditions, an increase in sports injuries due to higher participation rates, the prevalence of manual labor jobs leading to musculoskeletal disorders, sedentary lifestyles contributing to muscle stiffness and pain, and a lack of exercise causing muscle atrophy and pain. The muscle pain treatment market size is expected to see strong growth in the next few years. It will grow to " $16.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing adoption of non-opioid and non-invasive pain management treatments, rising healthcare expenditures and demand for effective pain management solutions, regulatory approvals for new pain management therapies and devices, emphasis on preventive healthcare to mitigate chronic pain conditions, and growing demand for alternative therapies like acupuncture and chiropractic care. Major trends in the forecast period include telehealth and virtual consultations for pain management, the development of wearable pain relief devices and smart clothing, biopharmaceutical innovations in pain treatment, AI-driven personalized pain management solutions, and regenerative medicine techniques for tissue repair and pain reduction. For further insights on this market, request a sample here

The muscle pain treatmentmarket covered in this report is segmented –
1) By Pharmacological Treatment: Analgesics; Muscle Relaxants; Topical Analgesics; Other Pharmacological Treatments
2) By Non-Pharmacological Treatment: Physical Therapy; Massage Therapy; Acupuncture; Heat And Cold Therapy; Exercise And Stretching; Other Non-Pharmacological Treatments
3) By Type Of Pain: Acute Muscle Pain; Chronic Muscle Pain
4) By Cause Of Muscle Pain: Overuse And Strain; Injury Or Trauma; Inflammatory Conditions; Neurological Conditions; Infections; Other Cause Of Muscle Pain
5) By Application: Hospital; Clinic; Other Applications Subsegments:
1) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Acetaminophen
2) By Muscle Relaxants: Centrally Acting Muscle Relaxants; Peripherally Acting Muscle Relaxants
3) By Topical Analgesics: Creams & Ointments; Gels & Sprays; Patches
4) By Other Pharmacological Treatments: Corticosteroids; Antidepressants; Anticonvulsants For further insights on this market,
request a sample here

North America was the largest region in the muscle pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the muscle pain treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy. For further insights on this market, request a sample here.

Major trends in this market include Innovative Solutions Driving Growth In The Muscle Pain Treatment Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon